منشور
A major pharmaceutical company has been accused of tampering with clinical trial data for a drug worth $3.7 billion. Patients are reportedly dying from liver failure, and the FDA has recommended an immediate withdrawal. However, Amgen is pushing back. The story began in 2021, when a small biotech firm called ChemoCentryx was involved. Here is the full thread:
2mo
10 إعجابات0 عدم إعجاب5 إعادات نشر10 التعليقات
?
التعليقات
لا توجد تعليقات بعد. كن أول من يعلّق!